AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia.
Golemovic M, Verstovsek S, Giles F, Cortes J, Manshouri T, Manley PW, Mestan J, Dugan M, Alland L, Griffin JD, Arlinghaus RB, Sun T, Kantarjian H, Beran M.
Golemovic M, et al. Among authors: arlinghaus rb.
Clin Cancer Res. 2005 Jul 1;11(13):4941-7. doi: 10.1158/1078-0432.CCR-04-2601.
Clin Cancer Res. 2005.
PMID: 16000593